Zydus Lifesciences Limited (Formerly known as ... Cadila Healthcare announced that the company has received a warning letter by the USFDA relating to its Moraiya formulation facility and Ahmedabad ...

Indian markets closed on a positive note on Monday with the 30-share Sensex gaining 454 points or 0.59 per cent to settle at ...

Stocks like SH Kelkar and Company, Ashoka Buildcon, Vodafone Idea, Bharti Airtel, Coal India, Power Grid Corporation, Nuvoco Vistas Corporation, Ador Welding, Vakrangee, InterGlobe Aviation, Piramal ...

The company has received a Letter of Intent from the Resolution Professional ... a US-based biopharmaceutical company wholly owned by Zydus Lifesciences, and Fortress Biotech Inc, announced ...

Zydus Lifesciences: Sentynl Therapeutics Inc ... The company has received a Letter of Intent from the Resolution Professional and will make phased investments in Vadraj Cement over 15 months.

Sonalis Consumer Pro - Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Rights Issue Draft Letter Of Offer. Dear Sir/Madam,Pursuant to Regulation 30 of the SEBI (Listing ...

Indian stock markets experienced volatility as the Sensex fell 329.92 points (0.43%) to 76,190.46 and the NIFTY dropped ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The designation ...

Zydus Lifesciences Ltd share price was down by -3.65% from the previous closing price of ₹957.60. Who are peers of Zydus Lifesciences Ltd? The peers of Zydus Lifesciences Ltd are Sun ...

The initial burst of new launches by Sun, Cipla, Zydus and Lupin are in the mid-to-late stage of product lifecycle. However, the industry as a whole has been downplaying the threat from trade ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...